Status:
COMPLETED
Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
The Sophie Davis School of Biomedical Education The City College of New York
City University of New York
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to understand why Hispanic/Latino patients with lung cancer are diagnosed later than other groups.
Eligibility Criteria
Inclusion
- Self-identified Hispanic/Latino patients with biopsy-proven primary lung cancer treated at MSKCC, including stages of disease I-IV
- 18 years of age or older
- Fluent in English or Spanish
- Patients must reside in the U.S
Exclusion
- Spanish-surnamed patients who do not self identify as Hispanic/Latino (e.g., Philippines-born individuals)
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01466946
Start Date
November 1 2011
End Date
February 1 2016
Last Update
February 11 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065